A new orthomolecular protocol for treating multiple sclerosis and related diseases.
D001205:Ascorbic Acid / Q000627:therapeutic use*; D001206:Ascorbic Acid Deficiency / Q000188:drug therapy*; D006801:Humans; D007372:Interferons; D009103:Multiple Sclerosis / Q000188:drug therapy*; D014777:Virus Diseases / Q000188:drug therapy
D007372:Interferons; D001205:Ascorbic Acid